Hémorragie, épilepsie et céphalées associées aux malformations artérioveineuses cérébrales : la cohorte de Lariboisière
Christian Stapf(University of Leicester), Emmanuel Houdart(Université Paris Cité), Raphaël Porcher(Hotel Dieu Hospital), Jean‐Pierre Saint‐Maurice(Center for Discrete Mathematics and Theoretical Computer Science), Béatrice Garcin(Université Paris Cité), M.-G. Bousser(Assistance Publique – Hôpitaux de Paris), Éric Manchon(Yves Rocher (France))
Cited by 0
Related Papers
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
|The Lancet|2013|1.2k
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation
|Neurology|2006|783
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection
|The Lancet Neurology|2015|464